To establish a serial ascertainement of specimens from patients with bone sarcomas to be
used in ongoing cytogenetic and molecular genetic analyses. These data will be integrated
and correlated with the established Orthopaedic Service clinical database.
- Patients must be undergoing diagnostic biopsy or resection of their primary or
metastatic bone sarcoma for therapeutic purposes.
- The specimen must be large enough to allow routine pathological analysis, with the
specimen for research excised from residual tissue that would otherwise be discarded.